Compare Sana Biotechnology Inc (SANA) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs BlackRock TCP Capital Corp — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M). The key difference: Sana Biotechnology Inc is far larger — about 3.2× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 26.09% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | TCPC | |
|---|---|---|
Market Cap | $873.84M | $270.17M |
Sector | Health | Financials |
52-Week High | $5.92 | $7.64 |
52-Week Low | $2.68 | $3.14 |
Enterprise Value | $848.03M | — |
Dividend Yield | — | 26.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
